Embarc

Bioclonetics Immunotherapeutics, Inc.

CIK: 1701251•TX•Incorporated: 2009-12-24

Latest Reported Offering

$200,000
Target Amount
$1,000,000
Maximum Amount
2017-09-29
Deadline

Security Details

Type: Other
Price per share: $1.00
Price set by: Pro-rated portion of the total principal value of $200,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
Shares offered: 200,000+

Offering Costs

Cash commission: 4%
of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: —
No

Filing history

Form C family — 15 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
C-U020-23301Wefunder$200K target, up to $1M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2017-09-29The amount raised at the time of closing is $255,600.
C-AR/A020-23301WefunderRevenue $0 · net income -$223K · 4 employees—
C-AR020-23301WefunderRevenue $0 · net income $0 · 4 employees—
C-U020-23900StartEngine$10K target, up to $683K · Convertible Note at $1.00 · closes 2018-11-02The amount raised at the time of closing is $265,800.
C/A020-23900StartEngine$10K target, up to $683K · Convertible Note at $1.00 · closes 2018-11-02Issuer is extending their campaign.
C/A020-23900StartEngine$10K target, up to $683K · Convertible Note at $1.00 · closes 2018-09-03Issuer is extending their campaign, raising their maximum funding goal, and updating their financials.
C-AR020-23301WefunderRevenue $0 · net income -$201K · 4 employees—
C/A020-23900StartEngine$10K target, up to $148K · Convertible Note at $1.00 · closes 2018-07-02Issuer is extending their campaign and updating their financials.
C/A020-23900StartEngine$10K target, up to $148K · Convertible Note at $1.00 · closes 2018-04-30Update to offering document due to xml filing error.
C/A020-23900StartEngine$10K target, up to $148K · Convertible Note at $100.00 · closes 2018-04-30Issuer is extending, adjusting their minimum purchase price, and updating the terms of their offering.
C020-23900StartEngine$10K target, up to $148K · Convertible Note at $100.00 · closes 2018-04-04—
C-U020-23301Wefunder$200K target, up to $1M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2017-09-29The final number is $386,766.00 in investments.
C-U020-23301Wefunder$200K target, up to $1M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2017-09-29$415,214.00 in investments. Payments are still being processed; final number is yet to be determined.
C/A020-23301Wefunder$200K target, up to $1M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2017-10-08Personnel changes, updated disclosures regarding Dr. Joseph Cotropia medical license being revoked, and updated business plan.
C020-23301Wefunder$200K target, up to $1M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2017-10-08—
Embarc dashboard

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist
Open in the dashboard

Company Information

Legal Status
Corporation
Jurisdiction
TX
Date of Incorporation
2009-12-24

Latest Metrics

Employees3
Total Assets$1,195
Cash on Hand$1,195
Revenues$0.00
Net Income-$80,591

Crowdfunding Portals

StartEngine
Wefunder
The intermediaries named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.

SEC Filings

View all SEC filings